Skip to main navigation Skip to search Skip to main content

Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalBiology of Blood and Marrow Transplantation
Volume26
StatePublished - Nov 1 2020

Cite this